{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:47:49Z","timestamp":1782456469623,"version":"3.54.5"},"reference-count":72,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,6,1]]},"DOI":"10.3724\/abbs.2026074","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:49:37Z","timestamp":1776844177000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Tryptophan-substituted antimicrobial peptide temporin-1CEb:                     in vitro and                     in vivo antibacterial activity against clinically isolated multidrug-resistant                     Klebsiella pneumonia"],"prefix":"10.3724","author":[{"given":"Fengquan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejing","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/jac\/dkad033","volume":"78","author":"Igarashi Y","year":"2023","unstructured":"Igarashi Y, Takemura W, Liu X, Kojima N, Morita T, Chuang VTG, Enoki Y. Development of an optimized and practical pharmacokinetics\/pharmacodynamics analysis method for aztreonam\/nacubactam against carbapenemase-producing                         K. pneumoniae. J AntiMicrob ChemoTher, 2023, 78: 991-999.","journal-title":"J AntiMicrob ChemoTher"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2147\/IDR.S461903","volume":"Volume 17","author":"Liao Y","year":"2024","unstructured":"Liao Y, Gong J, Yuan X, Wang X, Huang Y, Chen X. Virulence factors and carbapenem-resistance mechanisms in hypervirulent                         Klebsiella pneumoniae. IDR, 2024, Volume 17: 1551-1559.","journal-title":"IDR"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"6946","DOI":"10.1038\/s41467-024-51213-z","volume":"15","author":"Wu K","year":"2024","unstructured":"Wu K, Lin X, Lu Y, Dong R, Jiang H, Svensson SL, Zheng J. RNA interactome of hypervirulent                         Klebsiella pneumoniae reveals a small RNA inhibitor of capsular mucoviscosity and virulence. Nat Commun, 2024, 15: 6946.","journal-title":"Nat Commun"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"e0010724","DOI":"10.1128\/spectrum.00107-24","volume":"12","author":"Wu Y","year":"2024","unstructured":"Wu Y, Yu W, Chu X, Zhang J, Jia P, Liu XY, Zhu Y. Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant                         Klebsiella pneumoniae. Microbiol Spectr, 2024, 12: e0010724.","journal-title":"Microbiol Spectr"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3390\/biom13071155","volume":"13","author":"Jakubec M","year":"2023","unstructured":"Jakubec M, Rylandsholm FG, Rainsford P, Silk M, Bril\u2019kov M, Kristoffersen T, Juskewitz E. Goldilocks dilemma: LPS works both as the initial target and a barrier for the antimicrobial action of cationic AMPs on E. coli. Biomolecules, 2023, 13: 1155.","journal-title":"Biomolecules"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/13543776.2020.1851679","volume":"30","author":"Annunziato G","year":"2020","unstructured":"Annunziato G, Costantino G. Antimicrobial peptides (AMPs): a patent review (2015\u20132020). Expert Opin Ther Patents, 2020, 30: 931-947.","journal-title":"Expert Opin Ther Patents"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.it.2008.12.003","volume":"30","author":"Lai Y","year":"2009","unstructured":"Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol, 2009, 30: 131-141.","journal-title":"Trends Immunol"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"127822","DOI":"10.1016\/j.micres.2024.127822","volume":"286","author":"Bucataru C","year":"2024","unstructured":"Bucataru C, Ciobanasu C. Antimicrobial peptides: opportunities and challenges in overcoming resistance. Microbiol Res, 2024, 286: 127822.","journal-title":"Microbiol Res"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3390\/antibiotics10091095","volume":"10","author":"Rima M","year":"2021","unstructured":"Rima M, Rima M, Fajloun Z, Sabatier JM, Bechinger B, Naas T. Antimicrobial peptides: a potent alternative to antibiotics. Antibiotics, 2021, 10: 1095.","journal-title":"Antibiotics"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"616979","DOI":"10.3389\/fmicb.2021.616979","volume":"12","author":"Dijksteel GS","year":"2021","unstructured":"Dijksteel GS, Ulrich MMW, Middelkoop E, Boekema BKHL. Review: lessons learned from clinical trials using antimicrobial peptides (AMPs). Front Microbiol, 2021, 12: 616979.","journal-title":"Front Microbiol"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"106363","DOI":"10.1016\/j.ejps.2022.106363","volume":"181","author":"Luo X","year":"2023","unstructured":"Luo X, Chen H, Song Y, Qin Z, Xu L, He N, Tan Y. Advancements, challenges and future perspectives on peptide-based drugs: focus on antimicrobial peptides. Eur J Pharm Sci, 2023, 181: 106363.","journal-title":"Eur J Pharm Sci"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"e40121","DOI":"10.1016\/j.heliyon.2024.e40121","volume":"10","author":"Neghabi Hajigha M","year":"2024","unstructured":"Neghabi Hajigha M, Hajikhani B, Vaezjalali M, Samadi Kafil H, Kazemzadeh Anari R, Goudarzi M. Antiviral and antibacterial peptides: mechanisms of action. Heliyon, 2024, 10: e40121.","journal-title":"Heliyon"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd3591","volume":"11","author":"Fjell CD","year":"2011","unstructured":"Fjell CD, Hiss JA, Hancock REW, Schneider G. Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov, 2011, 11: 37-51.","journal-title":"Nat Rev Drug Discov"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fchem.2018.00204","volume":"6","author":"Hollmann A","year":"2018","unstructured":"Hollmann A, Martinez M, Maturana P, Semorile LC, Maffia PC. Antimicrobial peptides: interaction with model and biological membranes and synergism with chemical antibiotics. Front Chem, 2018, 6: 204.","journal-title":"Front Chem"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"e1004786","DOI":"10.1371\/journal.pcbi.1004786","volume":"12","author":"Diener C","year":"2016","unstructured":"Diener C, Garza Ramos Mart\u00ednez G, Moreno Blas D, Castillo Gonz\u00e1lez DA, Corzo G, Castro-Obregon S, Del Rio G. Effective design of multifunctional peptides by combining compatible functions. PLoS Comput Biol, 2016, 12: e1004786.","journal-title":"PLoS Comput Biol"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.coph.2006.04.006","volume":"6","author":"Marr A","year":"2006","unstructured":"Marr A, Gooderham W, Hancock R. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol, 2006, 6: 468-472.","journal-title":"Curr Opin Pharmacol"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0005-2736(99)00198-4","volume":"1462","author":"Epand RM","year":"1999","unstructured":"Epand RM, Vogel HJ. Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta (BBA)-Biomembranes, 1999, 1462: 11-28.","journal-title":"Biochim Biophys Acta (BBA)-Biomembranes"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bcp.2016.09.018","volume":"133","author":"Ageitos JM","year":"2017","unstructured":"Ageitos JM, S\u00e1nchez-P\u00e9rez A, Calo-Mata P, Villa TG. Antimicrobial peptides (AMPs): ancient compounds that represent novel weapons in the fight against bacteria. Biochem Pharmacol, 2017, 133: 117-138.","journal-title":"Biochem Pharmacol"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1021\/jp064776j","volume":"111","author":"Khandelia H","year":"2007","unstructured":"Khandelia H, Kaznessis YN. Cation-\u03c0 interactions stabilize the structure of the antimicrobial peptide indolicidin near membranes:\u2009 molecular dynamics simulations. J Phys Chem B, 2007, 111: 242-250.","journal-title":"J Phys Chem B"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2108\/zsj.26.220","volume":"26","author":"Shang D","year":"2009","unstructured":"Shang D, Yu F, Li J, Zheng J, Zhang L, Li Y. Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog,                         Rana chensinensis. Zool Sci, 2009, 26: 220-226.","journal-title":"Zool Sci"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ja.2014.4","volume":"67","author":"Bi X","year":"2014","unstructured":"Bi X, Wang C, Dong W, Zhu W, Shang D. Antimicrobial properties and interaction of two Trp-substituted cationic antimicrobial peptides with a lipid bilayer. J Antibiot, 2014, 67: 361-368.","journal-title":"J Antibiot"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/jam.12262","volume":"115","author":"Bi X","year":"2013","unstructured":"Bi X, Wang C, Ma L, Sun Y, Shang D. Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action. J Appl Microbiol, 2013, 115: 663-672.","journal-title":"J Appl Microbiol"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1747-0285.2012.01363.x","volume":"79","author":"Shang D","year":"2012","unstructured":"Shang D, Li X, Sun Y, Wang C, Sun L, Wei S, Gou M. Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, temporin-1CEb from Chinese brown frog,                         Rana chensinensis. Chem Biol Drug Des, 2012, 79: 653-662.","journal-title":"Chem Biol Drug Des"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/bip.21316","volume":"92","author":"Mant CT","year":"2009","unstructured":"Mant CT, Kovacs JM, Kim H-, Pollock DD, Hodges RS. Intrinsic amino acid side-chain hydrophilicity\/hydrophobicity coefficients determined by reversed-phase high-performance liquid chromatography of model peptides: comparison with other hydrophilicity\/hydrophobicity scales. Biopolymers, 2009, 92: 573-595.","journal-title":"Biopolymers"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/299371a0","volume":"299","author":"Eisenberg D","year":"1982","unstructured":"Eisenberg D, Weiss RM, Terwilliger TC. The helical hydrophobic moment: a measure of the amphiphilicity of a helix. Nature, 1982, 299: 371-374.","journal-title":"Nature"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/bioinformatics\/btg251","volume":"19","author":"Carver T","year":"2003","unstructured":"Carver T, Bleasby A. The design of Jemboss: a graphical user interface to EMBOSS. Bioinformatics, 2003, 19: 1837-1843.","journal-title":"Bioinformatics"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s10123-024-00481-2","volume":"27","author":"Shao H","year":"2024","unstructured":"Shao H, Zhang X, Li Y, Gao Y, Wang Y, Shao X, Dai L. Epidemiology and drug resistance analysis of bloodstream infections in an intensive care unit from a children\u2019s medical center in Eastern China for six consecutive years. Int Microbiol, 2024, 27: 1345-1355.","journal-title":"Int Microbiol"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.diagmicrobio.2013.01.001","volume":"75","author":"Sader HS","year":"2013","unstructured":"Sader HS, Flamm RK, Jones RN. Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011). Diagnostic Microbiol Infect Dis, 2013, 75: 417-422.","journal-title":"Diagnostic Microbiol Infect Dis"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"e00213-21","DOI":"10.1128\/JCM.00213-21","volume":"59","author":"Humphries R","year":"2021","unstructured":"Humphries R, Bobenchik AM, Hindler JA, Schuetz AN, McAdam AJ. Overview of changes to the clinical and laboratory standards institute Performance standards for antimicrobial susceptibility testing, m100, 31st edition. J Clin Microbiol, 2021, 59: e00213-21.","journal-title":"J Clin Microbiol"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bcp.2017.07.017","volume":"143","author":"Shang D","year":"2017","unstructured":"Shang D, Meng X, Zhang D, Kou Z. Antibacterial activity of chensinin-1b, a peptide with a random coil conformation, against multiple-drug-resistant                         Pseudomonas aeruginosa. Biochem Pharmacol, 2017, 143: 65-78.","journal-title":"Biochem Pharmacol"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3389\/fmicb.2019.02719","volume":"10","author":"Shang D","year":"2019","unstructured":"Shang D, Liu Y, Jiang F, Ji F, Wang H, Han X. Synergistic antibacterial activity of designed trp-containing antibacterial peptides in combination with antibiotics against multidrug-resistant                         Staphylococcus epidermidis. Front Microbiol, 2019, 10: 2719.","journal-title":"Front Microbiol"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"12241","DOI":"10.1021\/bi00163a038","volume":"31","author":"Park NG","year":"1992","unstructured":"Park NG, Lee S, Oishi O, Aoyagi H, Iwanaga S, Yamashita S, Ohno M. Conformation of tachyplesin I from Tachypleus tridentatus when interacting with lipid matrixes. Biochemistry, 1992, 31: 12241-12247.","journal-title":"Biochemistry"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1021\/bi051711i","volume":"45","author":"Lequin O","year":"2006","unstructured":"Lequin O, Ladram A, Chabbert L, Bruston F, Convert O, Vanhoye D, Chassaing G. Dermaseptin S9, an \u03b1-helical antimicrobial peptide with a hydrophobic core and cationic termini. Biochemistry, 2006, 45: 468-480.","journal-title":"Biochemistry"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/AAC.26.4.546","volume":"26","author":"Loh B","year":"1984","unstructured":"Loh B, Grant C, Hancock RE. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of                         Pseudomonas aeruginosa. Antimicrob Agents Chemother, 1984, 26: 546-551.","journal-title":"Antimicrob Agents Chemother"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1128\/AAC.49.7.2959-2964.2005","volume":"49","author":"Pankey GA","year":"2005","unstructured":"Pankey GA, Ashcraft DS. In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant                         Pseudomonas aeruginosa. Antimicrob Agents Chemother, 2005, 49: 2959-2964.","journal-title":"Antimicrob Agents Chemother"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/infdis\/168.1.164","volume":"168","author":"Bakker-Woudenberg IAJM","year":"1993","unstructured":"Bakker-Woudenberg IAJM, Lokerse AF, Kate MT, Mouton JW, Woodle MC, Storm G. Liposomes with prolonged blood circulation and selective localization in                         Klebsiella pneumoniae-infected lung tissue. J Infect Dis, 1993, 168: 164-171.","journal-title":"J Infect Dis"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0014-5793(99)00443-3","volume":"449","author":"Matsuzaki K","year":"1999","unstructured":"Matsuzaki K, Sugishita K, Miyajima K. Interactions of an antimicrobial peptide, magainin 2, with lipopolysaccharide-containing liposomes as a model for outer membranes of Gram-negative bacteria. FEBS Lett, 1999, 449: 221-224.","journal-title":"FEBS Lett"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.biomaterials.2014.10.041","volume":"37","author":"Sun Y","year":"2015","unstructured":"Sun Y, Dong W, Sun L, Ma L, Shang D. Insights into the membrane interaction mechanism and antibacterial properties of chensinin-1b. Biomaterials, 2015, 37: 299-311.","journal-title":"Biomaterials"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1128\/AAC.00045-08","volume":"53","author":"Sharma S","year":"2009","unstructured":"Sharma S, Khan IA, Ali I, Ali F, Kumar M, Kumar A, Johri RK. Evaluation of the antimicrobial, antioxidant, and anti-inflammatory activities of hydroxychavicol for its potential use as an oral care agent. Antimicrob Agents Chemother, 2009, 53: 216-222.","journal-title":"Antimicrob Agents Chemother"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/jac\/dkl120","volume":"57","author":"Wei GX","year":"2006","unstructured":"Wei GX. Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J AntiMicrob ChemoTher, 2006, 57: 1100-1109.","journal-title":"J AntiMicrob ChemoTher"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.actbio.2016.01.019","volume":"33","author":"Shang D","year":"2016","unstructured":"Shang D, Zhang Q, Dong W, Liang H, Bi X. The effects of LPS on the activity of Trp-containing antimicrobial peptides against Gram-negative bacteria and endotoxin neutralization. Acta BioMater, 2016, 33: 153-165.","journal-title":"Acta BioMater"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"611009","DOI":"10.3389\/fmicb.2021.611009","volume":"12","author":"Shang D","year":"2021","unstructured":"Shang D, Han X, Du W, Kou Z, Jiang F. Trp-containing antibacterial peptides impair quorum sensing and biofilm development in multidrug-resistant                         Pseudomonas aeruginosa and exhibit synergistic effects with antibiotics. Front Microbiol, 2021, 12: 611009.","journal-title":"Front Microbiol"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1128\/AEM.03775-13","volume":"80","author":"Huang E","year":"2014","unstructured":"Huang E, Yousef AE, Kivisaar M. The lipopeptide antibiotic paenibacterin binds to the bacterial outer membrane and exerts bactericidal activity through cytoplasmic membrane damage. Appl Environ Microbiol, 2014, 80: 2700-2704.","journal-title":"Appl Environ Microbiol"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1128\/AAC.02321-13","volume":"58","author":"Mohanram H","year":"2014","unstructured":"Mohanram H, Bhattacharjya S. Resurrecting inactive antimicrobial peptides from the lipopolysaccharide trap. Antimicrob Agents Chemother, 2014, 58: 1987-1996.","journal-title":"Antimicrob Agents Chemother"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/MMBR.00078-15","volume":"80","author":"Paczosa MK","year":"2016","unstructured":"Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev, 2016, 80: 629-661.","journal-title":"Microbiol Mol Biol Rev"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.diagmicrobio.2012.11.009","volume":"75","author":"van Duin D","year":"2013","unstructured":"van Duin D, Kaye KS, Neuner EA, Bonomo RA. Carbapenem-resistant enterobacteriaceae: a review of treatment and outcomes. Diagnostic Microbiol Infect Dis, 2013, 75: 115-120.","journal-title":"Diagnostic Microbiol Infect Dis"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1128\/AAC.05009-14","volume":"59","author":"Wand ME","year":"2015","unstructured":"Wand ME, Baker KS, Benthall G, McGregor H, McCowen JWI, Deheer-Graham A, Sutton JM. Characterization of pre-antibiotic era                         Klebsiella pneumoniae isolates with respect to antibiotic\/disinfectant susceptibility and virulence in                         Galleria mellonella. Antimicrob Agents Chemother, 2015, 59: 3966-3972.","journal-title":"Antimicrob Agents Chemother"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"Zasloff M","year":"2002","unstructured":"Zasloff M. Antimicrobial peptides of multicellular organisms. Nature, 2002, 415: 389-395.","journal-title":"Nature"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.4049\/jimmunol.0900712","volume":"184","author":"Niyonsaba F","year":"2010","unstructured":"Niyonsaba F, Ushio H, Hara M, Yokoi H, Tominaga M, Takamori K, Kajiwara N. Antimicrobial peptides human \u03b2-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. J Immunol, 2010, 184: 3526-3534.","journal-title":"J Immunol"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"117374","DOI":"10.1016\/j.ejmech.2025.117374","volume":"287","author":"Qi XL","year":"2025","unstructured":"Qi XL, Zhang HC, Xu X, Liu XW, Yang YJ, Li Z, Li JY. Discovery of novel thiazole-pleuromutilin derivatives with potent antibacterial activity. Eur J Med Chem, 2025, 287: 117374.","journal-title":"Eur J Med Chem"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/antibiotics14010099","volume":"14","author":"Sayem SAJ","year":"2025","unstructured":"Sayem SAJ, Lee GY, Abbas MA, Park SC, Lee SJ. Pharmacodynamic Profiling of amoxicillin: targeting multidrug-resistant Gram-positive pathogens                         Staphylococcus aureus and                         staphylococcus pseudintermedius in canine clinical isolates. Antibiotics, 2025, 14: 99.","journal-title":"Antibiotics"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11095-022-03425-5","volume":"40","author":"Liu X","year":"2023","unstructured":"Liu X, Tashiro S, Igarashi Y, Takemura W, Kojima N, Morita T, Hayashi M. Differences in pharmacokinetic\/pharmacodynamic parameters of tedizolid against VRE and MRSA. Pharm Res, 2023, 40: 187-196.","journal-title":"Pharm Res"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0006-3495(01)76039-0","volume":"80","author":"Shepherd CM","year":"2001","unstructured":"Shepherd CM, Schaus KA, Vogel HJ, Juffer AH. Molecular dynamics study of peptide-bilayer adsorption. Biophys J, 2001, 80: 579-596.","journal-title":"Biophys J"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1021\/bi702065b","volume":"47","author":"Torrent M","year":"2008","unstructured":"Torrent M, Navarro S, Moussaoui M, Nogu\u00e9s MV, Boix E. Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans. Biochemistry, 2008, 47: 3544-3555.","journal-title":"Biochemistry"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.bbamem.2006.03.021","volume":"1758","author":"Zelezetsky I","year":"2006","unstructured":"Zelezetsky I, Tossi A. Alpha-helical antimicrobial peptides\u2014using a sequence template to guide structure\u2013activity relationship studies. Biochim Biophys Acta (BBA)-Biomembranes, 2006, 1758: 1436-1449.","journal-title":"Biochim Biophys Acta (BBA)-Biomembranes"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1042\/bj20021255","volume":"370","author":"Shepherd CM","year":"2003","unstructured":"Shepherd CM, Vogel HJ, Tieleman DP. Interactions of the designed antimicrobial peptide MB21 and truncated dermaseptin S3 with lipid bilayers: Molecular-dynamics simulations. Biochem J, 2003, 370: 233-243.","journal-title":"Biochem J"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.1021\/bi00488a006","volume":"29","author":"De Kroon AIPM","year":"1990","unstructured":"De Kroon AIPM, Soekarjo MW, De Gier J, De Kruijff B. The role of charge and hydrophobicity in peptide-lipid interaction: a comparative study based on tryptophan fluorescence measurements combined with the use of aqueous and hydrophobic quenchers. Biochemistry, 1990, 29: 8229-8240.","journal-title":"Biochemistry"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1128\/jb.153.1.281-285.1983","volume":"153","author":"Nicas TI","year":"1983","unstructured":"Nicas TI, Hancock RE. Pseudomonas aeruginosa outer membrane permeability: isolation of a porin protein F-deficient mutant. J Bacteriol, 1983, 153: 281-285.","journal-title":"J Bacteriol"},{"key":"CITATION59","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/femsre\/fux010","volume":"41","author":"Hall CW","year":"2017","unstructured":"Hall CW, Mah TF. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev, 2017, 41: 276-301.","journal-title":"FEMS Microbiol Rev"},{"key":"CITATION60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4161\/viru.22718","volume":"4","author":"Shon AS","year":"2013","unstructured":"Shon AS, Bajwa RPS, Russo TA. Hypervirulent (hypermucoviscous)                         Klebsiella pneumoniae. Virulence, 2013, 4: 107-118.","journal-title":"Virulence"},{"key":"CITATION61","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.3389\/fmicb.2017.01944","volume":"8","author":"Li H","year":"2017","unstructured":"Li H, Li X, Song C, Zhang Y, Wang Z, Liu Z, Wei H. Autoinducer-2 facilitates                         Pseudomonas aeruginosa PAO1 Pathogenicity                         in vitro and                         in vivo. Front Microbiol, 2017, 8: 1944.","journal-title":"Front Microbiol"},{"key":"CITATION62","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.tim.2020.03.016","volume":"28","author":"Karygianni L","year":"2020","unstructured":"Karygianni L, Ren Z, Koo H, Thurnheer T. Biofilm matrixome: extracellular components in structured microbial communities. Trends Microbiol, 2020, 28: 668-681.","journal-title":"Trends Microbiol"},{"key":"CITATION63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/1040841X.2020.1842325","volume":"47","author":"Yin W","year":"2021","unstructured":"Yin W, Xu S, Wang Y, Zhang Y, Chou SH, Galperin MY, He J. Ways to control harmful biofilms: prevention, inhibition, and eradication. Crit Rev Microbiol, 2021, 47: 57-78.","journal-title":"Crit Rev Microbiol"},{"key":"CITATION64","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"Martin GS","year":"2003","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the united states from 1979 through 2000. N Engl J Med, 2003, 348: 1546-1554.","journal-title":"N Engl J Med"},{"key":"CITATION65","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1097\/00003246-200107001-00035","volume":"29","author":"Angus DC","year":"2001","unstructured":"Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med, 2001, 29: S109-S116.","journal-title":"Crit Care Med"},{"key":"CITATION66","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jss.2014.01.065","volume":"189","author":"Niu X","year":"2014","unstructured":"Niu X, Hu H, Li W, Li Y, Huang H, Mu Q, Yao H. Protective effect of total alkaloids on lipopolysaccharide-induced acute lung injury. J Surg Res, 2014, 189: 126-134.","journal-title":"J Surg Res"},{"key":"CITATION67","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s11655-023-3697-x","volume":"29","author":"Wang Y","year":"2023","unstructured":"Wang Y, Yu H, Liu T, Kong TC, Zheng Z, Wan Y, Bai C. Yinlai decoction protects microstructure of colon and regulates serum level of D-lactic acid in pneumonia mice fed with high-calorie and high-protein diet. Chin J Integr Med, 2023, 29: 714-720.","journal-title":"Chin J Integr Med"},{"key":"CITATION68","doi-asserted-by":"publisher","first-page":"1367422","DOI":"10.3389\/fmicb.2024.1367422","volume":"15","author":"Assoni L","year":"2024","unstructured":"Assoni L, Couto AJM, Vieira B, Milani B, Lima AS, Converso TR, Darrieux M. Animal models of                         Klebsiella pneumoniae mucosal infections. Front Microbiol, 2024, 15: 1367422.","journal-title":"Front Microbiol"},{"key":"CITATION69","doi-asserted-by":"publisher","first-page":"103421","DOI":"10.1016\/j.redox.2024.103421","volume":"78","author":"Pak SW","year":"2024","unstructured":"Pak SW, Kim WI, Lee SJ, Park SH, Cho YK, Kim JS, Kim JC. TXNIP regulates pulmonary inflammation induced by Asian sand dust. Redox Biol, 2024, 78: 103421.","journal-title":"Redox Biol"},{"key":"CITATION70","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1038\/s41467-025-59806-y","volume":"16","author":"Weissfuss C","year":"2025","unstructured":"Weissfuss C, Li J, Behrendt U, Hoffmann K, B\u00fcrkle M, Tan C, Krishnamoorthy G. Adjunctive phage therapy improves antibiotic treatment of ventilator-associated-pneumonia with                         Pseudomonas aeruginosa. Nat Commun, 2025, 16: 4500.","journal-title":"Nat Commun"},{"key":"CITATION71","doi-asserted-by":"publisher","first-page":"e01738-22","DOI":"10.1128\/aac.01738-22","volume":"67","author":"Gill CM","year":"2023","unstructured":"Gill CM, Nicolau DP. In vivo pharmacodynamic profile of EVER206, a novel polymyxin antimicrobial, against gram-negative bacteria in the murine thigh infection model. Antimicrob Agents Chemother, 2023, 67: e01738-22.","journal-title":"Antimicrob Agents Chemother"},{"key":"CITATION72","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1756-8722-4-28","volume":"4","author":"Jiang Y","year":"2011","unstructured":"Jiang Y, Jiang W, Qiu Y, Dai W. Effect of a structurally modified human granulocyte colony stimulating factor, G-CSFa, on leukopenia in mice and monkeys. J Hematol Oncol, 2011, 4: 28.","journal-title":"J Hematol Oncol"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/19F1E353CE7F4060A40791EE8FBD0218","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026074","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/19F1E353CE7F4060A40791EE8FBD0218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:11:58Z","timestamp":1782454318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":72,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026074","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}